Table 2 Association of SNPs with erythema for all patients as well as for the subgroups of patients with breast volume < or >750 cm³

Gene (codon)

Genotype

aa

n (%)

G0/1^a

G2/3^a

OR^b

95% CI^c

P^d

aa

n (%)

G0/1^a

G2/3^a

OR^b

95% CI^c

P^d

aa

n (%)

G0/1^a

G2/3^a

OR^b

95% CI^c

P^d

ATM

GG

63 (76)

28

35

1

36 (75)

20

16

1

27 (77)

8

19

1

0.19 – 5.68

(1853)

GA

18 (22)

9

9

1.18

0.45 – 3.25

0.826

11 (23)

6

5

1.43

0.38 – 5.67

0.573

7 (20)

3

4

0.92

0.04 – 32.21

1.000

AA

2 (2)

0

2

1.38

0.20 – 10.59

1 (2)

0

1

2.05

0.15 – 32.15

1 (3)

0

1

0.84

GSTP1

AA

37 (45)

19

18

1

21 (44)

12

9

1

16 (46)

7

9

1

(105)

AG

38 (45)

12

26

1.01

0.49 – 2.09

1.000

21 (44)

10

11

0.98

0.39 – 2.44

1.000

17 (48)

2

15

1.25

0.32 – 5.29

0.772

GG

8 (10)

6

2

1.02

0.24 – 4.35

6 (12)

4

2

0.96

0.15 – 5.97

2 (6)

2

0

1.56

0.10 – 28.03

TGFB1

CC

29 (35)

14

15

1

18 (38)

13

5

1

11 (31)

1

10

1

(pos-509)

CT

40 (48)

18

22

1.26

0.65 – 2.50

0.530

24 (50)

12

12

3.10

1.11 –10.21

0.028

16 (46)

6

10

0.36

0.10 – 1.14

0.083

TT

14 (17)

5

9

1.59

0.42 – 6.24

6 (12)

1

5

9.58

1.23 – 104.30

8 (23)

4

4

0.13

0.01 – 1.29

XPD ^e

GG

34 (42)

19

15

1

20 (43)

12

8

1

14 (40)

7

7

1

(751)

GT

38 (46)

14

24

1.85

0.90 – 4.00

0.098

20 (43)

10

10

1.42

0.59 – 3.59

0.420

18 (51)

4

14

3.95

0.91 – 22.75

0.046

TT

10 (12)

3

7

3.44

0.81 – 16.01

7 (14)

3

4

2.03

0.34 – 12.89

3 (9)

0

3

15.62

0.84 – 517.40

XRCC1

GG

36 (43)

17

19

1

25 (52)

14

11

1

11 (31)

3

8

1

(399)

GA

33 (40)

13

20

1.02

0.54 – 1.93

1.000

17 (35)

9

8

1.13

0.46 – 2.76

0.840

16 (46)

4

12

0.62

0.20 – 1.84

0.464

AA

14 (17)

7

7

1.04

0.29 – 3.73

6 (12)

3

3

1.27

0.21 – 7.63

8 (23)

4

4

0.39

0.04 – 3.39